A prospective cohort study of 27,111 women without cardiovascular disease at baseline reported a 62% increased risk of future LEAD in those with MetS, along with a strong association between MetS and elevated levels of CRP and sICAM‐1.72 Here, CRP is linked to metabolic syndrome.